TEAM

We closely collaborate with hospitals and universities as a team to accelerate brining meaningful impact in the field and improving the quality of life of the patients living with cholesterol-associated diseases. Our scientific advisory board is comprised of experts in the cardiovascular, renal, neurodegenerative, and other target diseases.

Leadership

HKIM_edited.png

Heegon Kim, PhD

CEO, Founder

Heegon Kim is the founder of RENATUS Inc., and a pioneer to study the effect of different cyclodextrins for the treatment of atherosclerosis. He perceived the needs for novel and safe cyclodextrins and their potential applicability in various cholesterol-associated diseases. With a vision to protect the world from cholesterol-associated diseases, he founded RENATUS. He obtained his PhD from Korea Advanced Institute of Science and Technology (KAIST). He was a postdoctoral fellow at Northwestern University Feinberg School of Medicine.